The emergence of Lilly’s bundling strategy for Zepbound and Taltz reflects the unregulated state of patient assistance programs in the commercial market and the need for Congressional intervention.

Former Vertex executive to spearhead the clinical development of Absci’s expanding AI-designed therapeutics pipeline ...

TD Cowen 46th Annual Health Care Conference March 2, 2026 1:10 PM ESTCompany ParticipantsKave Niksefat - Senior Vice President of ...

Hyperactive signaling pathways of some aggressive blood cancer cells can be tamped down by a previously unrecognized protein complex, ensuring the cancer's survival. If one component of the complex is ...

Ostarine held the promise of profound medical treatments. Something unexpected happened on the way to F.D.A. approval. By Jason Stallman Twenty-five years later, James Dalton proudly recalled “that ...

A federal judge in Illinois allowed a class action against Biogen Inc. to advance over the drugmaker’s alleged collusion with pharmacy benefit managers to favor its multiple sclerosis drug Tecfidera ...

Background: Hypertensive cerebral small vessel disease (CSVD) causes lacunar stroke, intraparenchymal hemorrhage (IPH), and cognitive impairment. Blood pressure (BP) control is the cornerstone of CSVD ...

Objectives To map the risk profile of drug classes at the population level by identifying associations between newly prescribed reimbursed drugs and sudden cardiac arrest (SCA), thereby providing a ...

Grocery chain Albertsons, which offers pharmacies, is suing the Cigna-owned pharmacy benefit manager Express Scripts for at least $10.9 million over alleged prescription underpayments, according to a ...

Sodium–glucose cotransporter-2 inhibitor use was associated with a significantly lower risk for dementia compared with dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes, while showing ...

Abstract: The process of finding reliable treatment for major depression and bipolar disorder can be arduous. The myriad behavioral symptoms presented by patients and resistance to treatment from ...

LOWERING DRUG PRICES FOR AMERICAN PATIENTS: Today, President Donald J. Trump announced nine new agreements with major pharmaceutical companies to lower prescription drug prices for Americans in line ...